Molecular Diagnostics
New mRNA Cancer Drivers Revealed in Chronic Lymphocytic Leukemia
New evidence has emerged showing that the inactivation or alteration of cancer suppressor genes can take place even if DNA itself remains unaltered. A known molecular mechanism for cancer development and spread is the inactivation of tumor suppressor genes, which encode various tools the body uses to keep its cells from turning cancerous. More...11 Sep 2018
In Other News
New Test Predicts Potential Success of BCG Immunotherapy for Bladder Cancer
Rapid Method Suggested for Diagnosis of DVT
Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Whole-Genome Sequencing Diagnoses Early Infantile Epileptic Encephalopathy
DNA Screening and Invasive Testing Show Similar Miscarriage Rates
Improved Myeloma Diagnosis Based on Blood Count Components
ELISA kit Offers Enhanced Diagnosis of Zika Virus Infection
Genotyping Assay Integrated into Glioma Treatment
Blood-Based Test Predicts Benefits of Lung Cancer Treatment
Genetic Mutation Identified in Childhood Brain Disorder
Biomarker-Based Blood Test Developed for Early Cancer Diagnosis
Genetic Testing for Hypercholesterolemia Improves Diagnosis
Epigenetic Diagnostic Tool Detects Diseases in Newborns
New Glioma Test Provides Answers during Surgical Procedures
Gene Test Distinguishes Kawasaki Disease from Other Illnesses
Urine Test Accurately Detects Bladder Cancer Recurrence
FDA Clears Diagnostic Assay for Group B Strep
Infections Defined in Urothelial Bladder Tumors
Fracture Risk Predicted with New Genetic Screen
Susceptible Genes Identified for Childhood Kidney Disease
Mutations Identified As Cause for Rare Bone Marrow Disorder
New Troponin Assays Receive US Marketing Clearance
MicroRNA Panel Delivers Thyroid Cancer Diagnosis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.